Ad

Loxo, Bayer drug for cancers driven by rare mutation gets U.S. nod

A Loxo Oncology Inc drug shown to be effective against a wide variety of cancers driven by a single, rare genetic mutation has won U.S. approval, the Food and Drug Administration announced on Monday.


Loxo, Bayer drug for cancers driven by rare mutation gets U.S. nod Loxo, Bayer drug for cancers driven by rare mutation gets U.S. nod Reviewed by jenisht on November 27, 2018 Rating: 5

No comments:

Powered by Blogger.